Immuron Limited reported unaudited net sales results for the year to date ended January 2024. For the period, the company reported sales of Travelan in Australia increased to AUD 2.1 million compared to AUD 0.3 million a year ago. Sales of Travelan in USA increased to AUD 0.6 million compared to AUD 0.3 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.091 AUD | -6.19% | -8.08% | +18.18% |
05-03 | Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director | CI |
04-10 | Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+18.18% | 14.54M | |
-3.65% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+53.68% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-6.08% | 8.3B |
- Stock Market
- Equities
- IMC Stock
- News Immuron Limited
- Immuron Limited Reports Unaudited Net Sales Results for the Year to Date Ended January 2024